Pulike Biological Engineering (SHSE:603566) Net Income From Continuing Operations : ¥138 Mil (TTM As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Pulike Biological Engineering Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Pulike Biological Engineering's net income from continuing operations for the three months ended in Mar. 2024 was ¥27 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2024 was ¥138 Mil.

Pulike Biological Engineering Net Income From Continuing Operations Historical Data

The historical data trend for Pulike Biological Engineering's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pulike Biological Engineering Net Income From Continuing Operations Chart

Pulike Biological Engineering Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Income From Continuing Operations

Get a 7-Day Free Trial

109.25

227.74

244.14

167.82

174.52

Pulike Biological Engineering Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Income From Continuing Operations	Get a 7-Day Free Trial															64.04	53.46	61.61	-4.59	27.31

Pulike Biological Engineering Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥138 Mil.

Pulike Biological Engineering (SHSE:603566) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pulike Biological Engineering Inc (SHSE:603566) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

N/A

Address

15th New governance, Henan Province, Luoyang, CHN, 471000

Website

http://www.pulike.com.cn

Pulike Biological Engineering Inc is engaged in the research and development and production and operation of veterinary drugs.

Executives

Sun Jin Zhong	Director
Zhang Zhen	Supervisors
Wang Zhu Yi	Supervisors
Ma Sui Ying	Director
Song Yong Jun	Director
Hu Wei	Director
Qiao Rong Cen	senior management
Zhou Li Peng	senior management
Tian Ke Gong	senior management
Kang Du Li	senior management
Zhao Rui	senior management
Qin De Chao	Director
Pei Lian Feng	senior management
Zhang Li Chang	Director
Zhang Xu Ke	Director

Pulike Biological Engineering (SHSE:603566) Headlines

No Headlines